31 completed, 7 unknown, 6 terminated, 4 active not recruiting. 56 Phase 2, 6 Phase 3, 5 Phase 1.
Follow Clarithromycin: new trials by email Literature Review of Clarithromycin trials Research Report on Clarithromycin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Testing a Novel Combination Treatment (Arm D) Versus Standard of Care for Intensive Phase Treatment for Mycobacterium Abscessus Pulmonary Disease in People With or Without Cystic Fibrosis in the Finding the Optimal Regimen for Mycobacterium Abscessus Treatment (FORMaT) Adaptive Platform Trial Sulbactam 25mg/kg -Durlobactam 25mg/kg (Every 6 hours), Ceftriaxone for Injection, Amoxicillin - Mycobacterium Abscessus Pulmonary Disease, Mycobacterium Abscessus Infection | Phase 2 | Not yet recruiting | The University of Queensland | 300 | 2027-04-01 | 2026-03-20 |
| Vonoprazan vs Proton Pump Inhibitor With Vitamin D or Probiotics Based Triple Therapy for Eradication of Helicobacter Pylori Infection Vonoparazan, Vitamin D, Probiotic - HELICOBACTER PYLORI INFECTIONS, Helicobacter Infection | Phase 2 | Recruiting | Tanta University | 132 | 2026-02-15 | 2026-09-09 |
| Study to Evaluate the Preliminary Efficacy of SKB264 and the Effect of Clarithromycin on the PK of SKB264 in OC SKB264, Clarithromycin - Ovarian Epithelial Cancer | Phase 2 | Active not recruiting | Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | 20 | 2026-01-16 | 2026-06-01 |
| Prospective Study of Frontline Antibiotics Therapy in the Treatment of Early-stage HP-negative Gastric MALT Lymphoma Esomeprazole, Bismuth tripotassium dicitrate, Tetracycline, and Metronidazole - MALT Lymphoma of Stomach | Phase 2 | Not yet recruiting | National Taiwan University Hospital | 40 | 2025-09-01 | 2025-08-27 |
| Perioperative Oxaliplatin With S-1 Combined H. Pylori Eradication in the Management of Locally Advanced Gastric Cancer Oxaliplatin With S-1 (SOX) Combined H. Pylori Eradication (Amoxicillin + clarithromycin + omeprazole + colloidal bismuth subcitrate), Oxaliplatin With S-1 (SOX) - Chemotherapy Effect | Phase 2 | Recruiting | Sixth Affiliated Hospital, Sun Yat-sen University | 198 | 2024-12-31 | 2026-08-06 |
| Efficacy and Safety of Black Seed Oil With Vonoprazan Based Triple Therapy in Treatment of Helicobacter Pylori Black Seed Oil Cap/Tab, Vonoprazan, Amoxicillin and Clarithromycin - Helicobacter Pylori Infection | Phase 2 | Active not recruiting | Ain Shams University | 90 | 2023-08-15 | 2026-09-14 |
| Furazolidone Quadruple Regimen Eradicate H. Pylori Infection Furazolidone, Clarithromycin - Helicobacter Pylori Infection, Eradication | Phase 1 / Phase 2 | Completed | Liaocheng People's Hospital | 493 | 2022-08-01 | 2025-02-12 |
| Treatment of Selinexor in Combination With Clarithromycin, Pomalidomide and Dexamethasone for Relapsed Refractory Multiple Myeloma Patients Selinexor, Clarithromycin, Pomalidomide - Myeloma Multiple, Myeloma | Phase 2 | Terminated | Weill Medical College of Cornell University | 4 | 2021-12-29 | 2023-10-25 |
| Beta-Lactam Containing Regimen for the Shortening of Buruli Ulcer Disease Therapy Standard [RC8]: rifampicin plus clarithromycin (RC) therapy for 8 weeks., Investigational [RCA4]: standard (RC) plus amoxicillin/clavulanate (A) for 4 weeks. - Buruli Ulcer | Phase 2 | Unknown | Fundacion Agencia Aragonesa para la Investigacion y Desarrollo (ARAID) | 140 | 2021-12-01 | 2024-05-16 |
| A Phase II Study of Daratumumab, Clarithromycin, Pomalidomide And Dexamethasone (D-ClaPd) In Multiple Myeloma Patients Previously Exposed to Daratumumab Daratumumab SC, Clarithromycin, Pomalidomide - Multiple Myeloma, Refractory Multiple Myeloma | Phase 2 | Active not recruiting | Weill Medical College of Cornell University | 11 | 2021-10-28 | 2026-05-20 |
| Recurrence Rate Comparison Between Esomeprazole and Lansoprazole in Eradicating Helicobacter Pylori Infection Among Children Esomeprazole, Lansoprazole, Amoxicillin - Helicobacter Pylori Infection | Phase 2 / Phase 3 | Completed | Finni Kollins | 51 | 2021-08-01 | 2023-05-17 |
| A Study of Bedaquiline Administered as Part of a Treatment Regimen With Clarithromycin and Ethambutol in Adult Patients With Treatment-refractory Mycobacterium Avium Complex-lung Disease (MAC-LD) Bedaquiline, Clarithromycin, Ethambutol - Treatment-refractory Mycobacterium Avium Complex-lung Disease (MAC-LD) | Phase 2 / Phase 3 | Completed | Janssen Pharmaceutical K.K. | 129 | 2021-01-08 | 2026-04-15 |
| Anti-inflammatory Clarithromycin for Improving COVID-19 Infection Early Clarithromycin - COVID-19, Virus Diseases | Phase 2 | Completed | Hellenic Institute for the Study of Sepsis | 90 | 2020-05-06 | 2021-01-11 |
| Finding the Optimal Regimen for Mycobacterium Abscessus Treatment Amikacin, Tigecycline, Imipenem - Pulmonary Disease Due to Mycobacteria (Diagnosis) | Phase 2 / Phase 3 | Recruiting | The University of Queensland | 300 | 2020-03-02 | 2026-05-11 |
| Clarithromycin Mechanisms in Hypersomnia Syndromes Clarithromycin, Placebo - Narcolepsy Without Cataplexy, Idiopathic Hypersomnia | Phase 2 | Completed | Emory University | 83 | 2019-09-04 | 2026-08-07 |
| Safety Trial of Herbal Melanin in Gastritis Patients Herbal Melanin, Nexium, Amoxil - Acid Dyspepsia, Gastritis | Phase 2 | Unknown | King Abdullah International Medical Research Center | 132 | 2018-03-01 | 2018-02-09 |
| Modulation of GABA-A Receptors in Parkinson Disease-Transdermal Flumazenil Arm Clarithromycin (Not used as of 4/2020), Placebo (Not used as of 4/2020), Transdermal flumazenil (Added 4/2020) - Parkinson Disease | Phase 1 / Phase 2 | Completed | Nicolaas Bohnen, MD, PhD | 34 | 2018-01-29 | 2023-01-10 |
| Flufenamic Acid for Hospitalised Influenza Infection FFA, clarithromycin, oseltamivir, Oseltamivir alone - Influenza A | Phase 2 | Unknown | The University of Hong Kong | 200 | 2018-01-08 | 2019-10-22 |
| Clarithromycin + Lenalidomide Combination: a Full Oral Treatment for Patients With Relapsed/Refractory Extranodal Marginal Zone Lymphoma clarithromycin and lenalidomide - Mucosa Associated Lymphoid Tissue (MALT) Lymphoma | Phase 2 | Completed | International Extranodal Lymphoma Study Group (IELSG) | 44 | 2017-04-03 | 2025-01-30 |
| Clarithromycin,Lenalidomide and Dexamethasone for Relapsed/Refractory Myeloma clarithromycin, Lenalidomide, Dexamethasone - Relapse/Refractory Multiple Myeloma | Phase 2 | Withdrawn | Sun Yat-sen University | 2016-12-01 | 2018-08-14 |
Showing 20 of 56. Sign in to see all of them.
Multiple Myeloma (16) · HIV Infections (5) · Lymphoma, B-Cell, Marginal Zone (5) · Mycobacterium avium-intracellulare Infection (5) · Acquired Immunodeficiency Syndrome (4) · Neoplasms, Plasma Cell (4) · Lymphoma (3) · Recurrence (3) · AIDS-Related Opportunistic Infections (2) · Aggressive Periodontitis (2) · Gastritis (2) · Helicobacter Infections (2) · Idiopathic Hypersomnia (2) · Infections (2) · Mycobacterium Infections, Nontuberculous (2)
Weill Medical College of Cornell University (6) · National Institute of Allergy and Infectious Diseases (NIAID) (4) · Fred Hutchinson Cancer Center (2) · Henrik Gregersen (2) · The University of Queensland (2) · Universidade Estadual Paulista Júlio de Mesquita Filho (2) · Ain Shams University (1) · Anderson Clinical Research (1) · Andres J. M. Ferreri (1) · Emory University (1) · European Organisation for Research and Treatment of Cancer - EORTC (1) · Finni Kollins (1) · Fundacion Agencia Aragonesa para la Investigacion y Desarrollo (ARAID) (1) · Hamamatsu University (1) · Hellenic Institute for the Study of Sepsis (1)
United States (25) · China (4) · Taiwan (4) · Denmark (3) · South Korea (3) · United Kingdom (3) · Brazil (2) · Egypt (2) · Italy (2) · Japan (2) · Australia (1) · Austria (1) · Benin (1) · Canada (1) · Germany (1)
Ruben Niesvizky, MD (3) · Henrik Gregersen, MD (2) · Leona Holmberg (2) · Adila SA Elobeid, PhD (1) · Andrew Wilcock (1) · Armando Sardi, M.D. (1) · Benson CA (1) · Bruce K Rubin, MEngr,MD,MBA (1) · Chaisson R (1) · Chaisson RE (1) · Charles Arthur Peloquin (1) · Chirgwin K (1) · Currier JS (1) · Drusano G (1)
PMID 16437639, PMID 17466292, PMID 17608775, PMID 1771934, PMID 17989313, PMID 20616418, PMID 23299315, PMID 24576165, PMID 25935794, PMID 26094838, PMID 27185079, PMID 28191328, PMID 28497487, PMID 30123673, PMID 30203587, PMID 30230047, PMID 30352784, PMID 30792190, PMID 31111585, PMID 31257591, PMID 31916648, PMID 32350723, PMID 33197289, PMID 34031871, PMID 34363189, PMID 35804454, PMID 36546422, PMID 37393120, PMID 38573915, PMID 38826786, PMID 40948663, PMID 42104494
2014 (1), P30CA015083 (1), P30CA015704 (1), P30CA016672 (1), R01NS099535 (1), R01NS111280 (1)